Cargando…

The Role of c-Met as a Biomarker and Player in Innate and Acquired Resistance in Non-Small-Cell Lung Cancer: Two New Mutations Warrant Further Studies

The c-Met receptor is a therapeutically actionable target in non-small-cell lung cancer (NSCLC), with one approved drug and several agents in development. Most suitable biomarkers for patient selection include c-Met amplification and exon-14 skipping. Our retrospective study focused on the frequency...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Der Steen, Nele, Zwaenepoel, Karen, Mazzaschi, Giulia, A. Luirink, Rosa, P. Geerke, Daan, Op de Beeck, Ken, Hermans, Christophe, Tiseo, Marcello, Van Schil, Paul, Lardon, Filip, Germonpré, Paul, Rolfo, Christian, Giovannetti, Elisa, J. Peters, Godefridus, Pauwels, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943481/ https://www.ncbi.nlm.nih.gov/pubmed/31817278 http://dx.doi.org/10.3390/molecules24244443

Ejemplares similares

Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer
por: Van Der Steen, Nele, et al.
Publicado: (2016)

Unlocking the potential of CD70 as a novel immunotherapeutic target for non-small cell lung cancer
por: Jacobs, Julie, et al.
Publicado: (2015)

New developments in the management of non-small-cell lung cancer, focus on rociletinib: what went wrong?
por: Van Der Steen, Nele, et al.
Publicado: (2016)

The MDM2-inhibitor Nutlin-3 synergizes with cisplatin to induce p53 dependent tumor cell apoptosis in non-small cell lung cancer
por: Deben, Christophe, et al.
Publicado: (2015)

Towards Prognostic Profiling of Non-Small Cell Lung Cancer: New Perspectives on the Relevance of Polo-Like Kinase 1 Expression, the TP53 Mutation Status and Hypoxia
por: Van den Bossche, Jolien, et al.
Publicado: (2017)

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance
por: Van Der Steen, Nele, et al.
Publicado: (2015)

MDM2 SNP309 and SNP285 Act as Negative Prognostic Markers for Non-small Cell Lung Cancer Adenocarcinoma Patients
por: Deben, Christophe, et al.
Publicado: (2017)

Krüppel-like factors in cancer progression: three fingers on the steering wheel
por: Limame, Ridha, et al.
Publicado: (2013)

c-Met as a Target for Personalized Therapy
por: Garajová, Ingrid, et al.
Publicado: (2015)

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy
por: Jacobs, Julie, et al.
Publicado: (2017)

Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function
por: Van Der Steen, Nele, et al.
Publicado: (2020)

Circulating Cell-Free DNA and RNA Analysis as Liquid Biopsy: Optimal Centrifugation Protocol
por: Sorber, Laure, et al.
Publicado: (2019)

Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?
por: Siozopoulou, Vasiliki, et al.
Publicado: (2021)

A Modified Arrhenius Approach to Thermodynamically Study Regioselectivity in Cytochrome P450‐Catalyzed Substrate Conversion
por: Luirink, Rosa A., et al.
Publicado: (2020)

Ozone Therapy as Adjuvant for Cancer Treatment: Is Further Research Warranted?
por: Clavo, Bernardino, et al.
Publicado: (2018)

Expression profiling of migrated and invaded breast cancer cells predicts early metastatic relapse and reveals Krüppel-like factor 9 as a potential suppressor of invasive growth in breast cancer
por: Limame, Ridha, et al.
Publicado: (2013)

The Army Medical Warrant
Publicado: (1876)

The Medical Warrant for India
Publicado: (1864)

Army Medical Warrant
Publicado: (1873)

The Medical Warrant for India
por: Wood, Charles
Publicado: (1865)

Warranting Dental Operations
por: Taft, J.
Publicado: (1862)

“Warranted” Dental Treatment
por: Schwamm, Henry
Publicado: (1914)

Warranting Dental Operations
Publicado: (1860)

Lower Respiratory Tract Infection in Children: When Are Further Investigations Warranted?
por: Dangor, Ziyaad, et al.
Publicado: (2021)

Evaluation of Cytologic Sample Preparations for Compatibility With Nucleic Acid Analysis
por: Sorber, Laure, et al.
Publicado: (2021)

Are Costs of Robot-Assisted Surgery Warranted for Gynecological Procedures?
por: van Dam, Peter, et al.
Publicado: (2011)

Imaging in otosclerosis: A pictorial review
por: Purohit, Bela, et al.
Publicado: (2014)

Role of MRI as first-line modality in the detection of previously undiagnosed otosclerosis: a single tertiary institute experience
por: Purohit, Bela, et al.
Publicado: (2020)

Comment on: Targeting the HGF/c-MET pathway in advanced pancreatic cancer: a key element of treatment that limits primary tumour growth and eliminates metastasis
por: Che, Pei Pei, et al.
Publicado: (2020)

Determination of the Potential Tumor-Suppressive Effects of Gsdme in a Chemically Induced and in a Genetically Modified Intestinal Cancer Mouse Model
por: Croes, Lieselot, et al.
Publicado: (2019)

Clinical pathways for inborn errors of metabolism: warranted and feasible
por: Demirdas, Serwet, et al.
Publicado: (2013)

Use of filters in anaesthesia: Is it warranted?
por: Chellam, Shrividya, et al.
Publicado: (2014)

Emphysematous pyelonephritis: Is nephrectomy warranted?
por: Alsharif, Mada, et al.
Publicado: (2015)

The New I. M. S. Warrant
Publicado: (1913)

New Army Medical Warrant
Publicado: (1877)

The New Army Medical Warrant
Publicado: (1876)

The New Indian Medical Warrant
Publicado: (1873)

Are variant-specific vaccines warranted?
por: Flemming, Alexandra
Publicado: (2022)

MET and Small-Cell Lung Cancer
por: Gelsomino, Francesco, et al.
Publicado: (2014)

pyAmpli: an amplicon-based variant filter pipeline for targeted resequencing data
por: Beyens, Matthias, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nrpq5rjfh1fvkslb4460fqhc9c